A pilot study to examine whether an intervention that includes foot massage has any effect on the experience of nausea and vomiting following chemotherapy received by cancer patients in the ambulatory care setting.

Cathie Pigott0 sites40 target enrollmentNovember 11, 2005

Overview

No summary available.

Registry

who.int

Start Date

November 11, 2005

End Date

TBD

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

Cathie Pigott

•To be eligible for the study, patients must be receiving chemotherapy in the ambulatory setting and: 1\)Be receiving a chemotherapy that is moderately or highly emetogenic (Class III or IV) as listed in the guidelines for antiemetics for chemotherapy\-induced emesis in adults; 2\)Receiving at least the second course of chemotherapy and planned to receive at least 1 further cycle of the regimen at least one week apart; 3\) Able to speak, read and write English sufficiently well to participate in the data collection process; 4\)agree to data extraction from their medical record; 5\)Have experienced nausea and/or vomiting since having chemotherapy.

•1\)Are under the care of a psychiatrist
•2\)Are scheduled to have chemotherapy as an in\-patient treatment in the next 48 hours;
•3\)Are receiving chemotherapy treatment delivered as an in\-patient;
•4\)Have a poor clinical performance status (ECOG \> 2\);
•5\)Have an open skin wounds on their feet;
•6\)Have a foot tumour or foot metastasis, or radiation treatment to the feet.
•7\)Have peripheral vascular disease
•8\)Have lymphatic or venous occlusion / obstruction affecting the lower limbs.